摘要
目的:探讨左氧氟沙星联合抗结核药治疗复治结核性胸膜炎的疗效。方法:收治复治结核性胸膜炎患者100例,随机分成观察组和对照组各50例,对照组采用2HRZE/4HR治疗方案,观察组在对照组基础上联合左氧氟沙星注射液。结果:观察组总有效率96.0%,对照组总有效率78.0%(P<0.05)。结论:左氧氟沙星联合抗结核药治疗复治结核性胸膜炎不良反应少,疗效显著。
ObjectiveTo evaluate the clinical efficacy of levofloxacin combined with anti tuberculosis drugs in the treatment ofrecurrent tuberculosis pleurisy.Methods：100 patients with recurrent tuberculous pleurisy were selected.They were randomlydivided into the observation group and the control group with 50 cases in each group.The control group was treated with 2HRZE/4HR therapy.The observation group combined with levofloxacin injection on the basis of the control group.Results：The totaleffective rate of the observation group was 96%,and the total effective rate of the control group was 78%（P〈0.05）.Conclusion：Theadverse reactions of levofloxacin combined with anti tuberculosis drugs in the treatment of recurrent tuberculous pleurisy is little,and the curative effect is remarkable.
出处
《中国社区医师》
2016年第33期34-34,36,共2页
Chinese Community Doctors
关键词
左氧氟沙星
复治
结核性胸膜炎
抗结核药
Levofloxacin
Retreatment
Tuberculous pleurisy
Anti tuberculosis drugs
